|
|
||||||||
European Journal of Cardio-Thoracic Surgery, Vol 6, 138-142, Copyright © 1992 by European Association for Cardio-thoracic Surgery
K Wong, CM Waters and RK Walesby
The treatment of haematological malignancies with intensive chemotherapy
and bone marrow transplantation results in prolonged periods of
immunosuppression. This is associated with an increased incidence of
invasive pulmonary aspergillosis (IPA) with reported mortalities of 67-83%.
The mainstay of treatment is medical therapy, surgery being reserved for
patients with haemoptysis. Resection of focal sites of infection has not
been routinely considered in view of the high morbidity and mortality
reported from the surgery of aspergillomas in past series. After the death
of two neutropenic patients from massive haemoptysis following IPA in 1986,
we have resected localised pulmonary aspergillus lesions in 16 patients
following IPA. Five patients had haemoptysis. The most common procedure
performed was a lobectomy. All patients were granulocytopenic and excessive
post-operative bleeding occurred in three patients, one of whom required a
re-thoracotomy as a result. There was one post- operative death due to
cytomegalovirus pneumonia. Surgery was otherwise uneventful. There were no
recurrent pulmonary aspergillus infections on follow-up and three patients
proceeded to bone marrow transplantation. The success of surgical resection
encourages an aggressive policy in the management of IPA to prevent
life-threatening haemoptysis and to allow patients to proceed with further
chemotherapy and bone marrow transplantation.
ARTICLES
Surgical management of invasive pulmonary aspergillosis in immunocompromised patients
University Department of Surgery, Royal Free Hospital, London, UK.
This article has been cited by other articles:
![]() |
H. Brodoefel, M. Vogel, H. Hebart, H. Einsele, R. Vonthein, C. Claussen, and M. Horger Long-term CT follow-up in 40 non-HIV immunocompromised patients with invasive pulmonary aspergillosis: kinetics of CT morphology and correlation with clinical findings and outcome. Am. J. Roentgenol., August 1, 2006; 187(2): 404 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takemoto, Y. Yamamoto, Y. Ueda, Y. Sumita, K. Yoshida, and Y. Niki Comparative study on the efficacy of AmBisome and Fungizone in a mouse model of pulmonary aspergillosis J. Antimicrob. Chemother., April 1, 2006; 57(4): 724 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.M. Habicht, M. Preiss, J. Passweg, P. Dalquen, P. Matt, H. Adler, R. Frei, and H.-R. Zerkowski Invasive pulmonary aspergillosis: effects of early resection in a neutropenic rat model Eur. J. Cardiothorac. Surg., November 1, 2002; 22(5): 728 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Caillot, J.-F. Couaillier, A. Bernard, O. Casasnovas, D. W. Denning, L. Mannone, J. Lopez, G. Couillault, F. Piard, O. Vagner, et al. Increasing Volume and Changing Characteristics of Invasive Pulmonary Aspergillosis on Sequential Thoracic Computed Tomography Scans in Patients With Neutropenia J. Clin. Oncol., January 1, 2001; 19(1): 253 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Habicht, F. Reichenberger, A. Gratwohl, H.-R. Zerkowski, and M. Tamm Surgical aspects of resection for suspected invasive pulmonary fungal infection in neutropenic patients Ann. Thorac. Surg., August 1, 1999; 68(2): 321 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Latge Aspergillus fumigatus and Aspergillosis Clin. Microbiol. Rev., April 1, 1999; 12(2): 310 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. REICHENBERGER, J. HABICHT, A. KAIM, P. DALQUEN, F. BERNET, R. SCHLAPFER, P. STULZ, A. P. PERRUCHOUD, A. TICHELLI, A. GRATWOHL, et al. Lung Resection for Invasive Pulmonary Aspergillosis in Neutropenic Patients with Hematologic Diseases Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 885 - 890. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Salerno, D. W. Ouyang, T. S. Pederson, D. M. Larson, J. P. Shake, E. M. Johnson, and M. A. Maddaus Surgical Therapy for Pulmonary Aspergillosis in Immunocompromised Patients Ann. Thorac. Surg., May 1, 1998; 65(5): 1415 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Baron, B. Guillaume, P. Moreau, P. Germaud, P. Despins, A. Y. De Lajartre, J. L. Michaud, S. :, and W. A. Fry Aggressive surgical management in localized pulmonary mycotic and nonmycotic infections for neutropenic patients with acute leukemia: Report of eighteen cases J. Thorac. Cardiovasc. Surg., January 1, 1998; 115(1): 63 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bernard, D. Caillot, J. F. Couaillier, O. Casasnovas, H. Guy, and J. P. Favre Surgical Management of Invasive Pulmonary Aspergillosis in Neutropenic Patients Ann. Thorac. Surg., November 1, 1997; 64(5): 1441 - 1447. [Abstract] [Full Text] |
||||
![]() |
J. M. Habicht, A. Gratwohl, M. Tamm, J. Drewe, M. Proske, and P. Stulz DIAGNOSTIC AND THERAPEUTIC THORACIC SURGERY IN LEUKEMIA AND SEVERE APLASTIC ANEMIA J. Thorac. Cardiovasc. Surg., June 1, 1997; 113(6): 982 - 988. [Abstract] [Full Text] |
||||
![]() |
L. A. Robinson, E. C. Reed, T. A. Galbraith, A. Alonso, A. L. Moulton, and W. H. Fleming Pulmonary resection for invasive Aspergillus infections in immunocompromised patients J. Thorac. Cardiovasc. Surg., June 1, 1995; 109(6): 1182 - 1197. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |